Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach.
Wyvekens N, Valtcheva N, Mischo A, Helmchen B, Hermanns T, Choschzick M, Hötker AM, Rauch A, Mühleisen B, Akhoundova D, Weber A, Moch H, Rupp NJ. Wyvekens N, et al. Among authors: akhoundova d. Genes Chromosomes Cancer. 2020 Nov;59(11):611-619. doi: 10.1002/gcc.22878. Epub 2020 Jul 7. Genes Chromosomes Cancer. 2020. PMID: 32537760
Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study.
Pietge H, Sánchez-Velázquez P, Akhoundova D, Siebenhüner A, Winder T, Bachmann H, Nguyen-Kim TDL, Breitenstein S, Knuth A, Petrowsky H, Pestalozzi B, Clavien PA, Samaras P. Pietge H, et al. Among authors: akhoundova d. Oncology. 2021;99(5):300-309. doi: 10.1159/000512967. Epub 2021 Mar 3. Oncology. 2021. PMID: 33657549 Free PMC article. Clinical Trial.
Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer.
Hiltbrunner S, Spohn ML, Wechsler R, Akhoundova D, Bankel L, Kasser S, Bihr S, Britschgi C, Maathuis MH, Curioni-Fontecedro A. Hiltbrunner S, et al. Among authors: akhoundova d. Cancers (Basel). 2021 Dec 24;14(1):75. doi: 10.3390/cancers14010075. Cancers (Basel). 2021. PMID: 35008239 Free PMC article.
Targeting ALK in Neuroendocrine Tumors of the Lung.
Akhoundova D, Haberecker M, Fritsch R, Höller S, Kiessling MK, Rechsteiner M, Rüschoff JH, Curioni-Fontecedro A. Akhoundova D, et al. Front Oncol. 2022 Jun 7;12:911294. doi: 10.3389/fonc.2022.911294. eCollection 2022. Front Oncol. 2022. PMID: 35756632 Free PMC article.
Improving the turnaround time of molecular profiling for advanced non-small cell lung cancer: Outcome of a new algorithm integrating multiple approaches.
Treichler G, Hoeller S, Rueschoff JH, Rechsteiner M, Britschgi C, Arnold F, Zoche M, Hiltbrunner S, Moch H, Akhoundova D, Opitz I, Curioni-Fontecedro A. Treichler G, et al. Among authors: akhoundova d. Pathol Res Pract. 2023 Aug;248:154660. doi: 10.1016/j.prp.2023.154660. Epub 2023 Jul 1. Pathol Res Pract. 2023. PMID: 37413876 Free article.
Alterations in homologous recombination repair genes in prostate cancer brain metastases.
Rodriguez-Calero A, Gallon J, Akhoundova D, Maletti S, Ferguson A, Cyrta J, Amstutz U, Garofoli A, Paradiso V, Tomlins SA, Hewer E, Genitsch V, Fleischmann A, Vassella E, Rushing EJ, Grobholz R, Fischer I, Jochum W, Cathomas G, Osunkoya AO, Bubendorf L, Moch H, Thalmann G, Ng CKY, Gillessen S, Piscuoglio S, Rubin MA. Rodriguez-Calero A, et al. Among authors: akhoundova d. Nat Commun. 2022 May 3;13(1):2400. doi: 10.1038/s41467-022-30003-5. Nat Commun. 2022. PMID: 35504881 Free PMC article.
30 results